Vivos Therapeutics, Inc. (VVOS)
0.1686
-0.03
(-13.98%)
USD |
NASDAQ |
Sep 01, 16:00
0.158
-0.01
(-6.29%)
After-Hours: 07:13
Vivos Therapeutics Cash from Operations (Annual) : -15.26M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -15.26M |
| December 31, 2024 | -12.69M |
| December 31, 2023 | -11.95M |
| December 31, 2022 | -19.59M |
| Date | Value |
|---|---|
| December 31, 2021 | -15.74M |
| December 31, 2020 | -5.680M |
| December 31, 2019 | -5.340M |
| December 31, 2018 | -5.418M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Hinge Health, Inc. | 171.44M |
| Exlites Holdings International, Inc. | 0.00 |
| Xcelerate, Inc. | -0.3789M |
| Haemonetics Corp. | 293.22M |
| Pro-Dex, Inc. | -1.682M |